PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

The success of trastuzumab and bevacizumab in breast and colorectal cancer ... pancreatic cancer. The role for other anti-VEGF and EGF receptor inhibitors continues to be investigated. Not only ...

Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening ...

Dr. Rahul S. Shinde, assistant professor in Wistar’s Ellen and Ronald Caplan Cancer Center, researches potential new therapies for treatment-resistant cancers like pancreatic cancer. In this ...

The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer (NSCLC) or pancreatic cancer. The drug is the first comprehensive ...

At the beginning of 2024, the American Cancer Society predicted that 2,001,140 new cancer cases and 611,720 ... and reflecting on the discoveries and advances that have been made in the field ...

I tell patients when they're diagnosed, it's about about 15-20% of patients with a new diagnosis of pancreatic cancer can actually talk to a surgeon," said Beard. Now they're finding they can ...

Atrium Health Navicent Peyton Anderson Cancer Center is offering new services to help patients with pancreatic and liver cancer. Dr. Salah Abdel Jalil says patients previously had to travel to Atlanta ...

Pancreatic cancer survival rates have more than doubled in the past decade. It's not because of a single breakthrough, but ...